DOCSLIB.ORG

Mathias Haag Dissertation 2010X

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mathias Haag Dissertation 2010X Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences presented by Mathias Haag, Dipl.-Ing. (FH) Born: 25 May 1981 in Darmstadt Oral examination: 17 December 2010 Development of Mass Spectrometric Methods for the Quantification of Membrane Lipids – Studies on Mitochondria, T Cells, Golgi Membranes and COPI Vesicles Referees: Prof. Dr. Felix Wieland PD. Dr. Britta Brügger 2 List of publications Christof Osman, Mathias Haag , Felix T. Wieland, Britta Brügger and Thomas Langer “A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4“ EMBO J. 2010. Jun 16; 29(12); 1976-1987. Christof Osman, Mathias Haag , Christoph Potting, Jonathan Rodenfels, Phat Vinh Dip, Felix T. Wieland, Britta Brügger, Benedikt Westermann and Thomas Langer “The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria” J. Cell Biol. 2009. Feb 23; 184(4); 583-596. 3 Table of contents Abbreviations .................................................................................................................. 7 Abstract ........................................................................................................................... 9 Zusammenfassung ........................................................................................................10 List of figures .................................................................................................................11 List of tables...................................................................................................................12 1 Introduction ..................................................................................................13 1.1 Biological membranes .................................................................................13 1.2 Structure, synthesis and function of membrane lipids .............................13 1.2.1 Glycerophospholipids .....................................................................................13 1.2.1.1 Cardiolipin (CL) ..............................................................................................16 1.2.1.2 Phosphoinositides (PIPs) ...............................................................................17 1.2.2 Glycerolipids ..................................................................................................18 1.2.2.1 Diacylglycerol (DAG) ......................................................................................18 1.2.3 Sphingolipids ..................................................................................................19 1.2.4 Sterol lipids ....................................................................................................20 1.3 Heterogeneity of lipid membranes ..............................................................21 1.4 Lipid transport mechanisms .......................................................................22 1.5 Nano-ESI-MS/MS for lipid quantification ....................................................23 1.5.1 Nano-ESI-MS/MS for quantification of CL, DAG and PIPs .............................24 1.6 Aims of the thesis ........................................................................................25 2 Results ..........................................................................................................27 2.1 Method development ...................................................................................27 2.1.1 Quantification of CL ........................................................................................27 2.1.1.1 Mass spectrometric characterization of CL molecular species ........................27 2.1.1.2 CL quantification in the presence of mitochondrial lipid extracts .....................30 2.1.1.3 Identification and quantification of CL in yeast mitochondria...........................31 2.1.2 Quantification of DAG.....................................................................................35 2.1.2.1 Mass spectrometric characterization of DAG molecular species ....................35 2.1.2.2 Identification and quantification of DAG by MPIS ...........................................37 2.1.2.3 Identification and quantification of DAG in Golgi membranes .........................40 2.1.3 Quantification of PIP and PIP 2 ........................................................................43 2.1.3.1 Extraction behavior of endogenous PIP and PIP 2 in HeLa cells ......................43 2.1.3.2 Mass spectrometric characterization of PIP and PIP 2 molecular species ........44 4 2.1.3.3 Identification and quantification of PIP and PIP 2 by neutral loss scanning ......46 2.1.3.4 Identification and quantification of PIP and PIP 2 in HeLa cells ........................48 2.2 Method application.......................................................................................51 2.2.1 Genetic interactors of prohibitins regulate mitochondrial PE and CL ..............51 2.2.1.1 Gep1 and Ups1 regulate the level of mitochondrial PE and CL ......................51 2.2.1.2 CL and PE profiles of mitochondria lacking GEP genes .................................53 2.2.1.3 A role for Gep4 in the biosynthesis of CL .......................................................54 2.2.1.3.1 PGP accumulates in ∆gep4 mitochondria .......................................................55 2.2.1.3.2 Gep4 dephosphorylates PGP in vitro .............................................................57 2.2.2 Ilimaquinone affects DAG level in Golgi membranes ......................................58 2.2.3 TCR stimulation affects PIP, PIP 2 and DAG levels in human T cells...............60 2.3 Quantitative lipid analysis of Golgi membranes and COPI vesicles.........62 2.3.1 Characterization of subcellular fractions and generation of COPI vesicles .....62 2.3.2 Quantitative lipid analysis of subcellular fractions ...........................................63 2.3.3 Distribution of lipid species in Golgi membranes and COPI vesicles ..............64 3 Discussion ....................................................................................................71 3.1 Method development ...................................................................................71 3.1.1 Quantification of CL ........................................................................................71 3.1.2 Quantification of DAG.....................................................................................72 3.1.3 Quantification of PIP and PIP 2 ........................................................................73 3.2 Method application.......................................................................................75 3.2.1 Genetic interactors of prohibitins regulate mitochondrial PE and CL ..............75 3.2.2 Ilimaquinone affects DAG level in Golgi membranes ......................................78 3.2.3 TCR stimulation affects PIP, PIP 2 and DAG levels in human T cells...............79 3.3 Quantitative lipid analysis of Golgi membranes and COPI vesicles.........80 3.3.1 Characterization of subcellular fractions and generation of COPI vesicles .....80 3.3.2 Quantitative lipid analysis of subcellular fractions ...........................................80 3.3.3 Distribution of lipid species in Golgi membranes and COPI vesicles ..............81 3.3.4 Mechanisms of segregation............................................................................82 4 Materials and methods ................................................................................84 4.1 Materials .......................................................................................................84 4.1.1 Chemicals and materials ................................................................................84 4.1.2 Lipids .............................................................................................................85 4.1.3 Instruments ....................................................................................................85 5 4.2 Methods ........................................................................................................85 3 4.2.1 Cell culture and myo -[ H]-inositol labeling ......................................................85 4.2.2 Phosphorus assay (micro determination) .......................................................86 4.2.3 Preparation of lipid standards .........................................................................86 4.2.4 Preparation of primary human T cells and TCR stimulation ............................86 4.2.5 Purification of Golgi membranes and COPI vesicles ......................................87 4.2.6 Lipid extraction procedures ............................................................................87 4.2.6.1 Lipid extraction from GEP mitochondria for PE and CL analysis ....................87 4.2.6.2 Lipid extraction from wt, ∆gep4 and ∆crd1 mitochondria ................................88 3 4.2.6.3 Phosphoinositide extraction from myo -[ H]-inositol labeled HeLa cells ...........89 4.2.6.4 Phosphoinositide extraction from HeLa cells ..................................................90 4.2.6.5 Lipid extraction from HeLa Golgi membranes for DAG quantification .............90 4.2.6.6 Lipid extraction from NRK Golgi membranes for DAG quantification ..............90 4.2.6.7 Lipid extraction
Load more

Recommended publications
  • Cardiolipin and Mitochondrial Cristae Organization
    Biochimica et Biophysica Acta 1859 (2017) 1156–1163 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Cardiolipin and mitochondrial cristae organization Nikita Ikon, Robert O. Ryan ⁎ Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, United States article info abstract Article history: A fundamental question in cell biology, under investigation for over six decades, is the structural organization of Received 23 December 2016 mitochondrial cristae. Long known to harbor electron transport chain proteins, crista membrane integrity is key Received in revised form 3 March 2017 to establishment of the proton gradient that drives oxidative phosphorylation. Visualization of cristae morphol- Accepted 18 March 2017 ogy by electron microscopy/tomography has provided evidence that cristae are tube-like extensions of the mito- Available online 20 March 2017 chondrial inner membrane (IM) that project into the matrix space. Reconciling ultrastructural data with the lipid Keywords: composition of the IM provides support for a continuously curved cylindrical bilayer capped by a dome-shaped Cardiolipin tip. Strain imposed by the degree of curvature is relieved by an asymmetric distribution of phospholipids in Mitochondria monolayer leaflets that comprise cristae membranes. The signature mitochondrial lipid, cardiolipin (~18% of Cristae IM phospholipid mass), and phosphatidylethanolamine (34%) segregate to the negatively curved monolayer leaf- Membrane curvature let facing the crista lumen while the opposing, positively curved, matrix-facing monolayer leaflet contains pre- Non-bilayer lipid dominantly phosphatidylcholine. Associated with cristae are numerous proteins that function in distinctive Electron transport chain ways to establish and/or maintain their lipid repertoire and structural integrity.
    [Show full text]
  • Serum from Pediatric Dilated Cardiomyopathy Patients Causes Dysregulation of Cardiolipin Biosynthesis and Mitochondrial Function Julie Pires Da Silva, Anastacia M
    Serum From Pediatric Dilated Cardiomyopathy Patients Causes Dysregulation of Cardiolipin Biosynthesis and Mitochondrial Function Julie Pires Da Silva, Anastacia M. Garcia, Carissa A. Miyano, Genevieve C. Sparagna, Raleigh Jonscher, Hanan Elajaili, and Carmen C. Sucharov. University of Colorado Anschutz Medical Campus, Aurora, CO Dilated Cardiomyopathy (DCM) Hypothesis - Dilated cardiomyopathy (DCM) is defined as a disorder characterized by Using a novel in vitro model of DCM-related cardiomyocyte remodeling that dilation and impaired contraction of the left ventricle or both ventricles. reproduces the molecular characteristics of pediatric DCM, we hypothesized that the alteration of mitochondrial function in NRVM treated - DCM is the most common form of cardiomyopathy and cause of heart with DCM pediatric sera is associate with changes in cardiolipin content and failure in children older than 1 year of age with an annual incidence of 0.57 mitochondrial β-oxidation pathway. per 100,000 children. - The causes of heart failure (HF) in children differ substantially from those Results found in the adult population and children do not respond well to adult HF therapies. Cardiolipin (CL) - Cardiolipin is a mitochondrial dimeric phospholipid normally located in the inner mitochondrial membrane Figure 5. DCM serum induces significant changes in metabolite levels involved in fatty acid oxidation pathway in NRVMs. A. Heatmap of 41 - CL represent 12-15% of phospholipid mass in heart. In the metabolites differentially expressed in NF and DCM serum-treated NRVMs. n = 4 NF, n= 4 DCM samples, p<0.05. B. Pathway enrichment map analysis heart, 70-80% is (18:2)4CL. of differential metabolites between NF and DCM groups using Figure 3.
    [Show full text]
  • Altered Traffic of Cardiolipin During Apoptosis: Exposure on the Cell Surface As a Trigger for (Antiphospholipid Antibodies)
    Hindawi Publishing Corporation Journal of Immunology Research Volume 2015, Article ID 847985, 9 pages http://dx.doi.org/10.1155/2015/847985 Review Article Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for (Antiphospholipid Antibodies) Valeria Manganelli,1 Antonella Capozzi,1 Serena Recalchi,1 Michele Signore,2 Vincenzo Mattei,1,3 Tina Garofalo,1 Roberta Misasi,1 Mauro Degli Esposti,4 and Maurizio Sorice1 1 Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy 2Department of Hematology, Oncology and Molecular Medicine, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy 3Laboratory of Experimental Medicine and Environmental Pathology, Sabina Universitas, Via dell’Elettronica, 02100 Rieti, Italy 4Italian Institute of Technology, Via Morego 30, 16136 Genoa, Italy Correspondence should be addressed to Maurizio Sorice; [email protected] Received 27 July 2015; Accepted 6 September 2015 Academic Editor: Douglas C. Hooper Copyright © 2015 Valeria Manganelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Apoptosis has been reported to induce changes in the remodelling of membrane lipids; after death receptor engagement, specific changes of lipid composition occur not only at the plasma membrane, but also in intracellular membranes. This paper focuses on one important aspect of apoptotic changes in cellular lipids, namely, the redistribution of the mitochondria-specific phospholipid, cardiolipin (CL). CL predominantly resides in the inner mitochondrial membrane, even if the rapid remodelling of its acyl chains and the subsequent degradation occur in other membrane organelles.
    [Show full text]
  • Role of Calcium-Independent Phospholipase A2 in the Pathogenesis of Barth Syndrome
    Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome Ashim Malhotraa, Irit Edelman-Novemskyb, Yang Xua, Heide Pleskenb, Jinping Mab, Michael Schlamea,b, and Mindong Renb,1 Departments of bCell Biology and aAnesthesiology, New York University Langone Medical Center, New York, NY 10016 Edited by David D. Sabatini, New York University School of Medicine, New York, NY, and approved December 23, 2008 (received for review November 6, 2008) Quantitative and qualitative alterations of mitochondrial cardio- is required for maintaining not only the normal CL fatty acyl lipin have been implicated in the pathogenesis of Barth syndrome, composition, but also normal CL levels. an X-linked cardioskeletal myopathy caused by a deficiency in Although it has been established that tafazzin deficiency tafazzin, an enzyme in the cardiolipin remodeling pathway. We causes both Barth syndrome and a derangement of CL metab- have generated and previously reported a tafazzin-deficient Dro- olism, evidence that it is, in fact, the CL deficiency that con- sophila model of Barth syndrome that is characterized by low tributes to Barth syndrome has been circumstantial (15). To cardiolipin concentration, abnormal cardiolipin fatty acyl compo- elucidate the pathogenic mechanism of Barth syndrome and to sition, abnormal mitochondria, and poor motor function. Here, we identify potential targets for therapeutic intervention, we have first show that tafazzin deficiency in Drosophila disrupts the final created a Drosophila model of Barth syndrome (7) by knocking stage of spermatogenesis, spermatid individualization, and causes out the tafazzin gene and have asked whether the resulting male sterility. This phenotype can be genetically suppressed by phenotypic changes can be suppressed by partially restoring CL inactivation of the gene encoding a calcium-independent phos- homeostasis without correcting the tafazzin defect.
    [Show full text]
  • Antioxidant Synergy of Mitochondrial Phospholipase PNPLA8/Ipla2γ with Fatty Acid–Conducting SLC25 Gene Family Transporters
    antioxidants Review Antioxidant Synergy of Mitochondrial Phospholipase PNPLA8/iPLA2γ with Fatty Acid–Conducting SLC25 Gene Family Transporters Martin Jab ˚urek 1,* , Pavla Pr ˚uchová 1, Blanka Holendová 1 , Alexander Galkin 2 and Petr Ježek 1 1 Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Vídeˇnská 1084, 14220 Prague, Czech Republic; [email protected] (P.P.); [email protected] (B.H.); [email protected] (P.J.) 2 Department of Pediatrics, Division of Neonatology, Columbia University William Black Building, New York, NY 10032, USA; [email protected] * Correspondence: [email protected]; Tel.: +420-296442789 Abstract: Patatin-like phospholipase domain-containing protein PNPLA8, also termed Ca2+-independent phospholipase A2γ (iPLA2γ), is addressed to the mitochondrial matrix (or peroxisomes), where it may manifest its unique activity to cleave phospholipid side-chains from both sn-1 and sn-2 posi- tions, consequently releasing either saturated or unsaturated fatty acids (FAs), including oxidized FAs. Moreover, iPLA2γ is directly stimulated by H2O2 and, hence, is activated by redox signaling or oxidative stress. This redox activation permits the antioxidant synergy with mitochondrial un- coupling proteins (UCPs) or other SLC25 mitochondrial carrier family members by FA-mediated Citation: Jab ˚urek, M.; Pr ˚uchová,P.; protonophoretic activity, termed mild uncoupling, that leads to diminishing of mitochondrial su- Holendová, B.; Galkin, A.; Ježek, P. peroxide formation. This mechanism allows for the maintenance of the steady-state redox status of Antioxidant Synergy of the cell. Besides the antioxidant role, we review the relations of iPLA2γ to lipid peroxidation since Mitochondrial Phospholipase iPLA2γ is alternatively activated by cardiolipin hydroperoxides and hypothetically by structural γ PNPLA8/iPLA2 with Fatty alterations of lipid bilayer due to lipid peroxidation.
    [Show full text]
  • Monolysocardiolipin (MLCL) Interactions with Mitochondrial Membrane Proteins
    Biochemical Society Transactions (2020) 48 993–1004 https://doi.org/10.1042/BST20190932 Review Article Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins Anna L. Duncan Department of Biochemistry, University of Oxford, Oxford, U.K. Correspondence: Anna L. Duncan ([email protected]) Monolysocardiolipin (MLCL) is a three-tailed variant of cardiolipin (CL), the signature lipid of mitochondria. MLCL is not normally found in healthy tissue but accumulates in mito- chondria of people with Barth syndrome (BTHS), with an overall increase in the MLCL:CL ratio. The reason for MLCL accumulation remains to be fully understood. The effect of MLCL build-up and decreased CL content in causing the characteristics of BTHS are also unclear. In both cases, an understanding of the nature of MLCL interaction with mitochondrial proteins will be key. Recent work has shown that MLCL associates less tightly than CL with proteins in the mitochondrial inner membrane, suggesting that MLCL accumulation is a result of CL degradation, and that the lack of MLCL–protein interac- tions compromises the stability of the protein-dense mitochondrial inner membrane, leading to a decrease in optimal respiration. There is some data on MLCL–protein interac- tions for proteins involved in the respiratory chain and in apoptosis, but there remains much to be understood regarding the nature of MLCL–protein interactions. Recent devel- opments in structural, analytical and computational approaches mean that these investi- gations are now possible. Such an understanding will be key to further insights into how MLCL accumulation impacts mitochondrial membranes. In turn, these insights will help to support the development of therapies for people with BTHS and give a broader under- standing of other diseases involving defective CL content.
    [Show full text]
  • Control of Free Arachidonic Acid Levels by Phospholipases A2 And
    Control of Free Arachidonic Acid Levels by Phospholipases A2 and Lysophospholipid Acyltransferases Gema Pérez-Chacón, Alma M. Astudillo, David Balgoma, María A. Balboa, and Jesús Balsinde* Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC), 47003 Valladolid, Spain, and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 08036 Barcelona, Spain *Corresponding author. Phone, +34-983-423-062; Fax, +34-983-184-800; e-mail: [email protected] Keywords: Arachidonic Acid; Phospholipase A2; Free fatty acid; Eicosanoids; Acyltransferase; Phospholipid Remodeling. Running Title: Control of Arachidonic Acid Levels 1 Abstract Arachidonic acid (AA) and its oxygenated derivatives, collectively known as the eicosanoids, are key mediators of a wide variety of physiological and pathophysiological states. AA, obtained from the diet or synthesized from linoleic acid, is rapidly incorporated into cellular phospholipids by the concerted action of arachidonoyl-CoA synthetase and lysophospholipid acyl transferases. Under the appropriate conditions, AA is liberated from its phospholipid storage sites by the action of one or various phospholipase A2 enzymes. Thus, cellular availability of AA, and hence the amount of eicosanoids produced, depends on an exquisite balance between phospholipid reacylation and hydrolysis reactions. This review focus on the enzyme families that are involved in these reactions in resting and stimulated cells. Abbreviations AA, arachidonic
    [Show full text]
  • An Essential Role for Cardiolipin in the Stability and Function of the Mitochondrial Calcium Uniporter
    An essential role for cardiolipin in the stability and function of the mitochondrial calcium uniporter Sagnika Ghosha, Writoban Basu Balla, Travis R. Madarisb, Subramanya Srikantanb, Muniswamy Madeshb, Vamsi K. Moothac,d,1, and Vishal M. Gohila,1 aDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843; bDepartment of Medicine, Division of Nephrology, Center for Precision Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229; cHoward Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; and dBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142 Contributed by Vamsi K. Mootha, May 24, 2020 (sent for review January 14, 2020; reviewed by Miriam L. Greenberg and Murali Prakriya) Calcium uptake by the mitochondrial calcium uniporter coordi- translocase Tim23 (13–15). The structural evidence for the role of nates cytosolic signaling events with mitochondrial bioenergetics. phospholipids in MCU function comes from a recent cryo- During the past decade all protein components of the mitochon- electron microscopy (EM) study that identified four lipid drial calcium uniporter have been identified, including MCU, the molecules on the membrane exposed surfaces of MCU, the pore-forming subunit. However, the specific lipid requirements, if pore-forming subunit (16). However, the molecular identities any, for the function and formation of this channel complex are and the roles of these lipids in MCU function were not currently not known. Here we utilize yeast, which lacks the mito- determined. chondrial calcium uniporter, as a model system to address this Deciphering the phospholipid requirements of the uniporter is problem.
    [Show full text]
  • The Relationship Between Phospholipids and Insulin Resistance: from Clinical to Experimental Studies
    Received: 22 July 2018 | Accepted: 2 October 2018 DOI: 10.1111/jcmm.13984 REVIEW The relationship between phospholipids and insulin resistance: From clinical to experimental studies Wenguang Chang1 | Grant M. Hatch2 | Yu Wang1 | Fei Yu1 | Man Wang1 1Center for Regenerative Medicine, Institute for Translational Medicine, Abstract Qingdao University, Qingdao, China Insulin resistance induced by high‐fat diet and impropriate life style is a major con- 2Departments of Pharmacology and tributor to the pathogenesis of metabolic disease. However, the underlying molecu- Therapeutics, Biochemistry and Medical Genetics, Center for Research and lar mechanisms remain unclear. Recent studies in metabolic dysfunction have Treatment of Atherosclerosis, DREAM extended this beyond simply elevated cholesterol and triglycerides levels and have Children's Hospital Research Institute of Manitoba, University of Manitoba, identified a key role for lipid metabolism. For example, altered phospholipid metabo- Winnipeg, MB, Canada lism has now become central in the pathogenesis of metabolic disease. In this Correspondence review, we discuss the association between insulin sensitivity and phospholipid Wenguang Chang, Center for Regenerative metabolism and highlight the most significant discoveries generated over the last Medicine, Institute for Translational Medicine, Qingdao University, Qingdao, several decades. Finally, we summarize the current knowledge surrounding the China. molecular mechanisms related to phospholipids and insulin resistance and provide Email:
    [Show full text]
  • Characterisation of Monolysocardiolipin Acyltransferase Activity
    CHARACTERISATION OF MONOLYSOCARDIOLIPIN ACYLTRANSFERASE ACTIVITY by BRIANJASON LAP-YENMA B-Sc. (H), The University of British Columbia, 1997 A thesis submitted in partial fulfilrnent of the requirements for the degree of THEFACULTY OF GRADUATESTUDIES Department of Pharmacology and Therapeutics THE UNTVERSITY OF MANITOBA July 2000 O Brian Jason Lap-Yen Ma, 2000 National Library Bibliothèque nationale l*l of Canada du Canada Acquisitions and Acquisitions et Bibliographie Services services bibliographiques 395 Wellington Street 395. rue Wellingtm OtcawaON KlAON4 OnawaON K1A ûN4 Canada canada The author has granted a non- L'auteur a accordé une licence non exclusive licence allowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sel1 reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/film, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or othenvise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. THE UNIVERSITY OF MANITOBA FACULTY OF GRADUATE STUDIES *te** COPYRIGHT PERMISSION PAGE Cbaracterisation of Monolysocardiolipin Acyltnnsferase
    [Show full text]
  • Characterization and Identification of Novel Regulators of the Synthesis of Phospholipids
    Wayne State University Wayne State University Dissertations 1-1-2014 Characterization And Identification Of Novel Regulators Of The yS nthesis Of Phospholipids Cunqi Ye Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Recommended Citation Ye, Cunqi, "Characterization And Identification Of Novel Regulators Of The yS nthesis Of Phospholipids" (2014). Wayne State University Dissertations. Paper 1036. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. CHARACTERIZATION AND IDENTIFICATION OF NOVEL REGULATORS OF THE SYNTHESIS OF PHOSPHOLIPIDS by CUNQI YE DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2014 MAJOR: BIOLOGICAL SCIENCES Approved by: ______________________________ Advisor Date ______________________________ ______________________________ ______________________________ © COPYRIGHT BY CUNQI YE 2014 All Rights Reserved DEDICATION 献给我的妻子陆帼蓉和儿子叶心州 献给我的父母和祖父母 To my wife, Guorong Lu, my son, Xinzhou Ye, my parents, sister, and grandparents, with all my love ii ACKNOWLEDGMENTS I am deeply indebted to Dr. Miriam L. Greenberg for her outstanding mentoring. Miriam’s enthusiasm and dedication to research truly inspired my passion in science. I am sincerely grateful to her numerous support and excellent guidance throughout my dissertation research in her laboratory. I must credit her vital offer of the scientific freedom, which nurtures my interests in the fascinating academic fields of lipids and mitochondria research. I would like to extend my gratitude and appreciation to my committee members, Drs. David Njus, Xiang-Dong Zhang, and Michael Bannon, for their valuable advice and support.
    [Show full text]
  • Mitochondria
    2184 Biophysical Journal Volume 100 May 2011 2184–2192 Cardiolipin Affects the Supramolecular Organization of ATP Synthase in Mitochondria Devrim Acehan,†‡ Ashim Malhotra,§ Yang Xu,§ Mindong Ren,† David L. Stokes,†‡{ and Michael Schlame†§* †Department of Cell Biology, ‡Skirball Institute, Structural Biology Program, and §Department of Anesthesiology, New York University School of Medicine, New York, New York; and {New York Structural Biology Center, New York, New York ABSTRACT F1F0 ATP synthase forms dimers that tend to assemble into large supramolecular structures. We show that the presence of cardiolipin is critical for the degree of oligomerization and the degree of order in these ATP synthase assemblies. This conclusion was drawn from the statistical analysis of cryoelectron tomograms of cristae vesicles isolated from Drosophila flight-muscle mitochondria, which are very rich in ATP synthase. Our study included a wild-type control, a cardiolipin synthase mutant with nearly complete loss of cardiolipin, and a tafazzin mutant with reduced cardiolipin levels. In the wild-type, the high- curvature edge of crista vesicles was densely populated with ATP synthase molecules that were typically organized in one or two rows of dimers. In both mutants, the density of ATP synthase was reduced at the high-curvature zone despite unchanged expression levels. Compared to the wild-type, dimer rows were less extended in the mutants and there was more scatter in the orientation of dimers. These data suggest that cardiolipin promotes the ribbonlike assembly of ATP synthase dimers and thus affects lateral organization and morphology of the crista membrane. INTRODUCTION In the mitochondrial inner membrane, a specific phospho- energy demands or metabolic activities.
    [Show full text]